
Organization · Fund of Funds
Ask Yggdrasil Venture Capital
Ask Yggdrasil Venture Capital is a Denmark-based fund-of-funds that invests in venture capital funds across the Americas and Europe, focusing on biotech, pharmaceutical, and technology sectors.
Overview
What Ask Yggdrasil Venture Capital does
What Ask Yggdrasil Venture Capital is
Ask Yggdrasil Venture Capital is a Denmark-based fund-of-funds that invests in venture capital funds across the Americas and Europe, focusing on biotech, pharmaceutical, and technology sectors.
How it participates in the startup ecosystem
The current public profile supports funder and allocator capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Fund of Funds
- Structured capabilities
- Funder · Allocator
- Last reviewed
- April 9, 2026
Official channels
Find Ask Yggdrasil Venture Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Ask Yggdrasil Venture Capital as a funder
Investment thesis
Ask Yggdrasil Venture Capital focuses on identifying unique venture capital fund opportunities to create a highly diversified portfolio.
Focus narrative
The firm invests in the biotech, pharmaceutical, and technology sectors through a fund-of-funds structure. By targeting early-stage investments, Ask Yggdrasil Venture Capital seeks to leverage the expertise of its underlying fund managers to identify promising opportunities across the Americas and Europe.
Value beyond capital
Ask Yggdrasil Venture Capital adds value by providing access to a diversified portfolio of venture capital funds, allowing investors to benefit from a broad range of opportunities while minimizing risk associated with individual startups.
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B · Series C · Series D
- Sectors
- Biotech & Life Sciences
- Regions
- Europe
Availability
- Currently deploying
- Not published
Capability profile
Ask Yggdrasil Venture Capital as an allocator
Allocator mandate
Ask Yggdrasil Venture Capital invests in the biotech, pharmaceutical, and technology sectors. They access venture capital funds across the Americas and Europe, targeting early-stage investments from pre-seed to series A-D.
Focus narrative
Ask Yggdrasil Venture Capital is a venture capital firm that focuses on identifying unique venture capital fund opportunities. The organization aims to create a highly diversified portfolio by investing in various sectors.
Value and partnership
The model is designed to maximize diversification and mitigate single-company risk by allocating capital to VC funds rather than directly to startups.
Availability and engagement
- Direct co-investment
- No
Mandate and fit
- Fund stages
- Seed Funds · Early Stage
- Asset classes
- Venture
- Sectors
- Biotech & Life Sciences
- Regions
- Americas · Europe
Connected ecosystem
Continue from Ask Yggdrasil Venture Capital
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about Ask Yggdrasil Venture Capital
Upseed classifies Ask Yggdrasil Venture Capital under the Fund of Funds organization type. Its current public profile includes funder and allocator capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.